Same Indication

Oseltamivir vs Tofacitinib

Oseltamivir vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Oseltamivir and Tofacitinib.

Mechanism of Action

Oseltamivir: Neuraminidase inhibitor preventing viral release from host cells.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Oseltamivir β€” 6-10 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Oseltamivir β€” C16H28N2O4; Tofacitinib β€” C16H20N6O.

Molecular Weight: Oseltamivir β€” 312.4050 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Oseltamivir β€” Small molecule; Tofacitinib β€” Small molecule.